reference/2526324

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2526324

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	2973
issn	0006-4971 1528-0020
issueIdentifier	19
pageRange	2968-2973
publicationName	Blood
startingPage	2968
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4dca07707f4cbfdd78bb53a174548146 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3db07583a7fc901c12570e51308c3760 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7d45dcf711b995277b509effcbae1b60
bibliographicCitation	Mallampati S, Leng X, Ma H, Zeng J, Li J, Wang H, Lin K, Lu Y, Yang Y, Sun B, Gong Y, Lee JS, Konopleva M, Andreeff M, Arlinghaus RB, Cai Z, Fang B, Shen H, Han X, Hirsch-Ginsberg CF, Gao X, Paranjape AN, Mani SA, Clise-Dwyer K, Sun X. Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia. Blood. 2015 May 07;125(19):2968–73. PMID: 25712988; PMCID: PMC4424418.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a14885c81a2a0ffdb20616fe69531f23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c32d5f746a0d3ceb35dcd71f1a944308 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdfb9ab9c78f4ca06833c49b699a14df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d89a83d568270758424c2d44c9a41d35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7335e366c4751885a03be51b214b8d1e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9da36185e53660176970dab0682b365 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04244a8246306d5955e7519769cbfa85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0393-8099 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12e4a63c30051ba2995384900b490709 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb078cf0ffc34835120f3a6b770ce093 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_044d835cfab7e78080707ed70f1e38d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5bb0fd7c49ba9f6500d30835ebe89ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_418d208fd7f3645a8bac063ff31b9d17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02d664de651aafb359d6a22e3b07174a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a44c939421c3889e59686bb5be518ae6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c96eee10f828b57fe806d666095a72e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b586dcf592cd461a2fee8d9f1413004b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4f6ec9799fee82acfe55086de3093d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74fff603dd22cc663865b1f624102ec5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4307d563395dd118ee9aa5ddcd973003 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db1be559d33f329abd4c2ebc97e4653d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fb6274ee4c9db2c579347f7c0381768 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_612d6c9e4c3411d225b044dd8f7932a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5479-9095 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f350465204e6832a789e53019cb1440c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cd693374537bf2752a6a569bd21da12
date	2015-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1182/blood-2014-05-576421 https://pubmed.ncbi.nlm.nih.gov/25712988 https://pubmed.ncbi.nlm.nih.gov/PMC4424418
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243 https://portal.issn.org/resource/ISSN/0006-4971 https://portal.issn.org/resource/ISSN/1528-0020
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Tyrosine kinase inhibitors induce mesenchymal stem cell–mediated resistance in BCR-ABL+ acute lymphoblastic leukemia
discusses	http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0024527 http://id.nlm.nih.gov/mesh/M0457532
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D054198Q000473 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D059630Q000473 http://id.nlm.nih.gov/mesh/D016044Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D054198Q000235 http://id.nlm.nih.gov/mesh/D054198Q000188 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D002471Q000187 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D020869 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D059630Q000187 http://id.nlm.nih.gov/mesh/D059630Q000378 http://id.nlm.nih.gov/mesh/D020411 http://id.nlm.nih.gov/mesh/D016044Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9876

Total number of triples: 79.